Mexico's SMSP public health institute ready for greater influence
This article was originally published in Clinica
Pablo Kuri Morales began his tenure as president of Mexico's public health institute, Sociedad Mexicana de Salud Pública, with the unveiling last week of its 2009-10 work plan. Its main aim is to strengthen its policy-generating influence and role as interlocutor between public health players (the document is available at: www.smsp.org.mx). The SMSP is a long-standing and influential non-governmental preventive healthcare policy body that ostensibly focuses on the under-covered segments of the population. Dr Kuri's medical and healthcare policy career has specialised in surgery (he is member of the national surgery academy) and epidemiological surveillance.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.